The mechanism of malignant transformation of CADM1-positive lung adenocarcinoma
Project/Area Number |
25460432
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Human pathology
|
Research Institution | Jichi Medical University (2015-2016) The University of Tokyo (2013-2014) |
Principal Investigator |
|
Project Period (FY) |
2013-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | CADM1 / RAPGEF2 / RAP1 / non-TRU type / lung adenocarcinoma / RAPGE2 / EMT / 肺腺癌 / PRMT5 |
Outline of Final Research Achievements |
Some invasive high-grade adenocarcinomas overexpress CADM1. Here, we investigated the characteristics of CADM1-positive high-grade subtype. In this study, we found that lung adenocarcinoma cell lines expressing CADM1 frequently show low level expressions of bronchial epithelial markers. Furthermore, these CADM1-positive cell lines co-express RAPGEF2. Knockdown of RAPGEF2 reduced cell migration and RAP1 activity, which suggested that RAPGEF2 promoted cell migration through activation of RAP1. In addition, our knockdown experiments of RAPGEF2 indicate that RAPGEF2 reduces the tumor suppressor function of CADM1. Immunohistochemical analysis of lung adenocarcinoma cases (n=140) revealed that high level expression of RAPGEF2 correlated with high-grade subtype, low level expressions of bronchial epithelial markers, and worse prognosis especially in CADM1-positive lung adenocarcinomas. In conclusion, RAPGEF2 will get involved in the malignant phenotype of CADM1-positive high grade subtype.
|
Report
(5 results)
Research Products
(25 results)
-
[Journal Article] Identification of cell-type-specific mutations in nodal T-cell lymphomas.2017
Author(s)
Nguyen TB, Sakata-Yanagimoto M, Asabe Y, Matsubara D, Kano J, Yoshida K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Izutsu K, Nakamura N, Takeuchi K, Miyoshi H, Ohshima K, Minowa T, Ogawa S, Noguchi M, Chiba S.
-
Journal Title
Blood Cancer Journal
Volume: 7
Issue: 1
Pages: e516-e516
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Pancreatic neuroendocrine tumor with metastasis to the spleen: a case report.2017
Author(s)
Sakuma Y, Yasuda Y, Sata N, Hosoya Y, Shimizu A, Fujii H, Matsubara D, Fukushima N, Miki A, Maeno M, Lefor AK.
-
Journal Title
BMC Cancer
Volume: 17
Issue: 1
Pages: 37-37
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Crohn's disease presenting as a ceco-urachal fistula.2017
Author(s)
Tsukui H, Koinuma K, Morimoto M, Horie H, Lefor AK, Kagaya Y, Takahashi H, Yano T, Matsubara D, Yamamoto H, Sata N.
-
Journal Title
Clin J Gastroenterol
Volume: 10
Issue: 1
Pages: 32-36
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
[Journal Article] Loss of YAP1 defines neuroendocrine differentiation of lung tumors.2016
Author(s)
Ito T, Matsubara D, Tanaka I, Makiya K, Tanei ZI, Kumagai Y, Shiu SJ, Nakaoka HJ, Ishikawa S, Isagawa T, Morikawa T, Shinozaki-Ushiku A, Goto Y, Nakano T, Tsuchiya T, Tsubochi H, Komura D, Aburatani H, Dobashi Y, Nakajima J, Endo S, Fukayama M, Sekido Y, Niki T, Murakami Y.
-
Journal Title
Cancer Science
Volume: 107
Issue: 10
Pages: 1527-1538
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.2016
Author(s)
Ikenoue T, Terakado Y, Nakagawa H, Hikiba Y, Fujii T, Matsubara D, Noguchi R, Zhu C, Yamamoto K, Kudo Y, Asaoka Y, Yamaguchi K, Ijichi H, Tateishi K, Fukushima N, Maeda S, Koike K, Furukawa Y
-
Journal Title
Sci Rep
Volume: 印刷中
Issue: 1
Pages: 23899-23899
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma2015
Author(s)
Shin Saito, Kazue Morishima, Takashi Ui, Hiroko Hoshino, Daisuke Matsubara, Shumpei Ishikawa, Hiroyuki Aburatani, Masashi Fukayama, Yoshinori Hosoya, Naohiro Sato, Alan K Lefor, Yoshikazu Yasuda and Toshiro Niki
-
Journal Title
BMC cancer
Volume: 15
Issue: 1
Pages: 1-12
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.2014
Author(s)
Ibrahim R, Matsubara D, Osman W, Morikawa T, Goto A, Morita S, Ishikawa S, Aburatani H, Takai D, Nakajima J, Fukayama M, Niki T, Murakami Y
-
Journal Title
Hum Pathol.
Volume: 45
Issue: 7
Pages: 1397-405
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Stromal fibroblasts are predictors of disease-related mortality in esophageal squamous cell carcinoma.2014
Author(s)
Saito S, Morishima K, Ui T, Matsubara D, Tamura T, Oguni S, Hosoya Y, Sata N, Lefor AT, Yasuda Y, Niki T.
-
Journal Title
Oncology Reports
Volume: 32
Issue: 1
Pages: 348-354
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Presentation] Loss of YAP1 defines neuroendocrine differentiation of lung tumor.2015
Author(s)
Matsubara D, Ito T, Tanaka I, Makiya K, Kumagai Y, Sue J, Shumpei I, Isagawa T, Morikawa T, Ushiku A, Goto Y, Nakano T, Tsuchiya T, Aburatani H, Dobashi Y, Nakajima J, Endo S, Fukayama M, Sekido Y, Niki T, and Murakami Y
Organizer
74th Annual Meeting of the Japanese Cancer Association
Place of Presentation
Nagoya Congress Center (Nagoya)
Year and Date
2015-10-08
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-